An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) By midwayadmin|2019-10-28T19:21:40+00:00October 28th, 2019| Read More
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults By midwayadmin|2019-10-28T19:20:19+00:00October 28th, 2019| Read More
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection By midwayadmin|2019-10-28T19:19:06+00:00October 28th, 2019| Read More
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children By midwayadmin|2019-10-28T19:16:32+00:00October 28th, 2019| Read More
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Adults Who Are Virologically Suppressed By midwayadmin|2019-10-28T19:15:17+00:00October 28th, 2019| Read More
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO) By midwayadmin|2019-10-28T19:13:31+00:00October 28th, 2019| Read More
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults By midwayadmin|2019-10-28T19:12:04+00:00October 28th, 2019| Read More
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study By midwayadmin|2019-10-28T19:10:27+00:00October 28th, 2019| Read More
Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants By midwayadmin|2019-10-28T19:08:05+00:00October 28th, 2019| Read More
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults By midwayadmin|2019-10-28T18:51:58+00:00July 10th, 2019| Read More
